Glovadalen

DB21709InvestigationalSmall molecule

Glovadalen is a small molecule drug. Glovadalen is under investigation in clinical trial NCT06970301 (A Study to Assess the Safety and Tolerability, and Pharmacokinetics of UCB0022 in Healthy Caucasian, Japanese,... Glovadalen has a monoisotopic molecular weight of 475.14 Da.

Formula / weight: C₂₄H₂₇Cl₂N₃O₃ · 476.4 g/mol (avg)
Code names: UCB0022

Resolves to

Compound

UNIIH8T5VKH4CZCAS2576359-31-2ChEMBLCHEMBL6068015ChEBI759933PubChem155460962

Structure

InChIKeySVTDEVFVOSMAQQ-UONOGXRCSA-NSMILESC[C@@H]1N([C@@H](CO)CC2=C1C=CC=C2C(C)(C)O)C(=O)CC1=C2C(Cl)=NN(C)C2=CC=C1Cl

What you can answer from here — as of September 23, 2026

4Clinical trialsPhase, status and sponsor resolved per trial

Which companies are running trials of Glovadalen, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account